Model
Edge
Alnylam Pharmaceuticals, Inc.
0001829252
Filing Type
4
Filing Date
10/2/2025
Updated
10/3/25, 3:12 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership